Argireline
Also known as: Acetyl Hexapeptide-8, Acetyl Hexapeptide-3
Argireline is a synthetic peptide used as a topical cosmetic ingredient, often marketed in anti-ageing formulations. It is a cosmetic ingredient, not a medicine.
- Category
- Cosmetic / Skin
- Reported half-life
- Not well established
- Common forms
- Topical cosmetic serums and creams, Cosmetic raw material solution
- Research status
- Used as a topical cosmetic ingredient in anti-ageing formulations; it is a cosmetic ingredient, not a medicine. Supporting evidence is largely laboratory- and formulation-based.
- Last updated
- 21 June 2026
Claimed effects
The following effects are reported or claimed by users and in early research. They are not established medical facts and many are not supported by large human trials.
- Reported to be associated with the appearance of reduced expression lines in topical use
- Reported to influence neurotransmitter-related signalling in laboratory studies
- Reported to be marketed as a topical alternative to certain cosmetic procedures
How it is reported to work
Argireline is proposed to mimic part of a protein involved in neurotransmitter release, with the idea that it may modestly reduce muscle contraction signalling near the skin surface. These proposed mechanisms come largely from in vitro work and cosmetic-formulation studies and should be regarded as preliminary rather than established.
Background
Argireline is a synthetic hexapeptide widely used as a topical cosmetic ingredient, often appearing in products marketed for the appearance of fine lines. This page is educational information, not medical advice, and the effects described below are reported claims, not established facts.
What the research shows
Most published material on Argireline comes from laboratory studies and cosmetic-formulation evaluations. These suggest possible cosmetic effects on the look of skin, but they do not establish medical benefit.
| Evidence type | Status |
|---|---|
| Laboratory (in vitro) studies | Present |
| Cosmetic formulation studies | Some |
| Large independent clinical trials | Limited |
| Australian medicine approval | Not applicable (cosmetic) |
What people use it for (reported)
In cosmetics, Argireline is reported to be included in serums marketed toward the appearance of expression lines. These are reported cosmetic-marketing claims, not validated clinical outcomes, and nothing here should be read as encouragement to use it in any particular way.
Things to be aware of
Argireline is a topical cosmetic ingredient, not a medicine. Its behaviour outside approved cosmetic products is not well understood, and grey-market preparations cannot be verified for purity or identity by sight. If you have a skin or health concern, the appropriate step is to speak with a qualified healthcare professional. This article does not recommend obtaining or using Argireline outside of approved cosmetic products. All effects described here remain reported claims, not established facts.
Reported positives & side effects
Compiled from research and community reports. These are reported outcomes, not guarantees or medical advice, individual experiences vary widely.
Reported positives
- Reported in topical use to be associated with the appearance of softened expression lines
- Reported to be linked with smoother-looking skin around the forehead and eyes
- Reported to be marketed as a topical alternative to certain cosmetic procedures
- Reported to be associated with an improved overall look of skin texture
Common side effects
- Reported mild redness or irritation at the application site
- Reported temporary tightness or tingling on application
- Reported dryness with frequent use
- Reported transient stinging when applied near the eyes
Rare / serious side effects
- Reported contact allergy or sensitisation to the peptide or formulation
- Reported eye irritation if applied too close to the eyes
- Reported reactions to contaminated or mislabelled unregulated raw material
Reported misuse & overdose risks
What has been reported to happen with overuse, excessive dosing, or long-term misuse of Argireline. Listed so you can make an informed decision, not to suggest any use is safe.
- Reported over-application or excessive layering, leading to irritation and a compromised skin barrier
- Reported expectation of 'injectable-like' results, prompting unsafe overuse of concentrated raw material
- Reported DIY mixing of unregulated raw powder of unverified purity into homemade serums
- Reported applying near or into the eyes against product guidance, risking irritation
Reported results timeline
Roughly how long people report it takes to notice effects. A general guide from reports, not a promise, and not advice. Users typically report gradual softening of expression lines over 4-12 weeks of regular topical application.
First effects
Some report smoother-feeling skin in the first couple of weeks
Noticeable change
Reported softening of fine expression lines with regular application
Clear results
Reported appearance changes described over a few months of consistent use
Commonly reported dosing & protocol
Reported figures only, NOT a recommendation or dosing advice. These are numbers people report using, compiled for education so you can make an informed decision. We do not advise anyone to take Argireline. Many peptides are not approved for human use in Australia. Speak to a qualified healthcare professional.
| Route | Topical serum/cream |
|---|---|
| Typical reported dose | Reported at roughly 5–10% |
| Frequency | Reported 1–2× daily applied to skin |
| Cycle length | Reported as ongoing, with results over weeks of regular use |
Reported topical use is commonly described as applying once or twice daily within a skincare routine, with reported results over 4-12 weeks of consistent application. This is reported information, not advice.
Best used with / commonly stacked with
Combinations people report using together. Reported, not recommended, stacking can increase risks.
Safety notes
Argireline is a topical cosmetic ingredient and is not a medicine. Its effects when used outside approved cosmetic products are not well characterised, and grey-market purity cannot be verified by consumers. Anyone with a skin or health concern should consult a qualified healthcare professional.